GDF-15 and/or Troponin T for Predicting Kidney Failure in Heart Surgery Patients
AssigneeRoche Diagnostics Operations, Inc.
InventorsAndrea Horsch, Dietmar Zdunek, Georg Hess
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to the field of laboratory diagnostics. Specifically, means and methods are disclosed for determining a patient's risk of suffering from acute kidney injury after a surgical procedure based on the detection of GDF-15, troponin T and/or a natriuretic peptide.
Claims20
A method for predicting a risk of acute kidney injury (AKI) in a patient subjected to a surgical procedure, comprising:
- a) contacting, in vitro, a sample obtained from the patient before the patient undergoes the surgical procedure with a ligand comprising specific binding affinity for GDF-15;
- b) determining the amount of GDF-15 in the sample;
- and
- c) providing a prediction that the patient is not at risk of AKI if the amount of GDF-15 is below about 1078 pg/ml, or that the patient has an increased risk of AKI if the amount of GDF-15 is above about 1717 pg/ml.
A method for predicting a risk of acute kidney injury (AKI) in a patient subjected to a surgical procedure, comprising:
- a) contacting, in vitro, a sample obtained from the patient after the patient undergoes the surgical procedure with an antibody immunoreactive for GDF-15;
- b) determining the amount of GDF-15 in the sample;
- and
- c) providing a prediction that the patient is not at risk of AKI if the amount of GDF-15 is below about 1807 pg/ml and that the patient has an increased risk of AKI if the amount of GDF-15 is above about 3389 pg/ml.
A device for predicting a risk of acute kidney injury (AKI) in a patient subjected to a surgical procedure, comprising:
- a) an analyzing unit comprising means for contacting, in vitro, a sample obtained from the patient before or after the patient undergoes the surgical procedure with a ligand comprising specific binding affinity for GDF-15, and means for determining the amount of GDF-15 in the sample;
- and
- b) an evaluation unit comprising a computer for comparing the determined amount of GDF-15 with a reference amount, predicting the risk of AKI during or immediately after the surgical procedure, and providing an output indicating the risk of AKI.
Dependencies are inferred from the claim text.